Skip to main content
Article
The Pre-Transplant Mantle Cell Lymphoma International Prognostic Index Predicts Overall and Progression-Free Survival Following High-Dose Therapy and Autologus Stem Cell Transplant for Mantle Cell Lymphoma
Blood (2011)
  • Leslie A Thompson, Seattle Cancer Care Alliance
  • Katherine A Guthrie, Fred Hutchinson Cancer Research Center
  • Lihua Elizabeth Budde, Fred Hutchinson Cancer Research Center
  • Brian G. Till, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • Thomas Chauncey, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Stephen H. Petersdorf, Fred Hutchinson Cancer Research Center
  • William I Bensinger, Fred Hutchinson Cancer Research Center
  • Leona Holmberg, Fred Hutchinson Cancer Research Center
  • Andrei R. Shustov, University of Washington Medical Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
Publication Date
November 18, 2011
Citation Information
Leslie A Thompson, Katherine A Guthrie, Lihua Elizabeth Budde, Brian G. Till, et al.. "The Pre-Transplant Mantle Cell Lymphoma International Prognostic Index Predicts Overall and Progression-Free Survival Following High-Dose Therapy and Autologus Stem Cell Transplant for Mantle Cell Lymphoma" Blood Vol. 118 Iss. 21 (2011) p. 2026 - 2026
Available at: http://works.bepress.com/john-pagel/168/